Abstract
Aims and Objective
To evaluate the prevalence, clinical features, diagnostic laboratory values and treatment outcome of giant cell lesions (brown tumors) associated with primary hyperparathyroidism (PHPT) in oral and maxillofacial region.
Study Design
A 5 year retrospective data was analyzed wherein all histopathologically proven cases of giant cell lesions involving oral and maxillofacial region were evaluated. Out of these cases, those associated with PHPT were tabulated. Correlation was established with other concomitant clinical features and also with the laboratory values of altered serum calcium, phosphate, alkaline phosphate and parathormone. Follow up of these cases after the correction of PHPT was also noted.
Result
Out of 85 cases of histopathologically proven giant cell lesions, five cases were associated with PHPT. There was involvement of maxilla and mandible in one case each. Only frontal bone was involved in two cases. Fifth case had multiple lytic lesions in maxilla and frontal bone. All patients consistently showed very high values of alkaline phosphate and parathormone. Hypercalcemia and hypophosphatemia was noted in four cases. All cases showed regression of the lytic lesion after parathyroidectomy obviating the need for surgical excision of the jaw lesions.
Conclusion
Giant cell lesions (brown tumors) associated with PHPT in oral and maxillofacial region are rare clinical entities. The prevalence of PHPT associated giant cell lesions is 5.9 %. They are clinically, radiologically and histopathologically similar to any other peripheral or central giant cell tumor. Relevant history may alert the clinician and altered biochemical values may help in correlating the oral and maxillofacial findings with the underlying systemic disease. At times, the brown tumor maybe the only presenting sign leading to the diagnosis of PHPT.
Similar content being viewed by others
References
Rao DS, Rao SD (2003) Treatment of primary hyperparathyroidism. Curr Opin Endocrinol Diabetes 10:394–399
Mithal A, Bandeira F, Meng X, Rao DS (2001) Clinical presentation of primary hyperparathyroidism in India, Brazil and China. In: Bilzeikian JP, Levine MA, Marcus R (eds) The Parathyroid. Academic Press, San Diego, CA, pp 375–376
Ahmad R, Hammond JM (2004) Primary, secondary and tertiary hyperparathyroidism. Otolaryngol Clin N Am 37:701–703
Padbury AD, Tozum TF, Taba M, Ealba EL, West BT, Burney RE et al (2006) The impact of primary hyperthyroidism on the oral cavity. J Clin Endocrinol Metab 9:3439–3445
Rai S, Bhadada SK, Rattan V, Bhansali A, Rao DS, Shah V (2012) Oro-mandibular manifestations of primary hyperparathyroidism. Indian J Dent Res 23:384–387
Martinez-Gavidia EM, Bagan JV, Milian-Masanet MA, de Lloria ME, Perez Valles A (2000) Highly aggressive brown tumour of the maxilla as first manifestation of primary hyperparathyroidism. Int J Oral Maxillofac Surg 29:447–449
Daniels S (2004) Primary hyperparathyroidism presenting as a palatal brown tumor. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98:409–413
Mohanty S, Jhamb A (2009) Central giant cell lesion of mandible managed by intralesional triamcinolone injections. A report of two cases and literature review. Med Oral Patol Oral Cir Bucal 14:98–102
Maskey R, Panchani R, Varma T, Goyal A (2013) Primary hyperparathyroidism in India: a cocktail of contemporary and classical presentations: Lesson from 47 cases. Indian J Endocrinol Metab 17:209–211
Gupta V (2013) Normocalcemic primary hyperparathyroidism in a patient with severe osteoporosis receiving teriparatide. Indian J Endocrinol Metab 17(2):336–338
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rai, S., Rattan, V. & Bhadada, S.K. Giant Cell Lesions Associated with Primary Hyperparathyroidism. J. Maxillofac. Oral Surg. 14, 930–934 (2015). https://doi.org/10.1007/s12663-014-0719-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12663-014-0719-4